Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Banting Postdoctoral Fellowship Program

University of Calgary

$140,000.00

The Endocannabinoid System in Glucocorticoid-Induced Metabolic Outcomes: A Focus on Genetic Variants of Fatty Acid Amide Hydrolase

FY 2017-18

Summary
Chronic stress, with the coordinated rise in stress hormones known as glucocorticoids (GCs, cortisol in humans), is a major risk factor for obesity. Evidence suggests that GC actions underlie the effects of chronic stress on energy balance. Yet the relationship between stress, GCs, and energy balance is highly complex. For example when confronted with stress, some individuals gain weight, whereas others lose weight. It is believed that an individual's response to stress and GCs is moderated by genetic variants. Nevertheless, genetic risk factors at the interface between energy balance and stress regulation remain elusive. In humans, there is a common genetic variant in the gene for fatty acid amide hydrolase (FAAH), present in ~38% of Europeans. This genetic variant (C385A) reduces levels of FAAH. This reduction in FAAH ultimately affects the endocannabinoid system since FAAH breaks down the endocannabinoid ligand anandamide. Indeed anandamide regulates energy balance and the stress response. Importantly, the low-expressing FAAH variant (A-allele carriers) has been associated with improved stress coping and increased rates of obesity in humans. Thus, the FAAH variant is positioned to moderate stress-induced metabolic outcomes. The proposed project will be the first to examine whether genetic variants of FAAH predict individual susceptibility to obesity in response to chronic GC exposure. We will employ a mouse model, which recapitulates the common human mutation in the FAAH gene (C385A), to investigate the effects of differential FAAH expression (between C- and A-allele carriers) on feeding and energy expenditure. This project has the potential to establish a molecular link between energy balance and stress, and help to explain why diverging metabolic outcomes arise when confronted with stress. Together, the outcomes of these studies may have implications for obesity prevention, via lifestyle modification (stress reduction) in genetically susceptible individuals.
Program
Banting Postdoctoral Fellowship Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
373689
Name
Balsevich Georgia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Banting Postdoctoral Fellowships Program
Projecttitle
The Endocannabinoid System in Glucocorticoid-Induced Metabolic Outcomes: A Focus on Genetic Variants of Fatty Acid Amide Hydrolase
Programtype2
Fellowship Programs
Orgnameinp2
University of Calgary
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
Banting Postdoctoral Fellowship Program
Keyworddelim
Endocannabinoids; Energy Balance; Fatty Acid Amide Hydrolase; Genetic Risk Factors; Glucocorticoids; Mouse Models; Stress
Abstract
Chronic stress, with the coordinated rise in stress hormones known as glucocorticoids (GCs, cortisol in humans), is a major risk factor for obesity. Evidence suggests that GC actions underlie the effects of chronic stress on energy balance. Yet the relationship between stress, GCs, and energy balance is highly complex. For example when confronted with stress, some individuals gain weight, whereas others lose weight. It is believed that an individual's response to stress and GCs is moderated by genetic variants. Nevertheless, genetic risk factors at the interface between energy balance and stress regulation remain elusive. In humans, there is a common genetic variant in the gene for fatty acid amide hydrolase (FAAH), present in ~38% of Europeans. This genetic variant (C385A) reduces levels of FAAH. This reduction in FAAH ultimately affects the endocannabinoid system since FAAH breaks down the endocannabinoid ligand anandamide. Indeed anandamide regulates energy balance and the stress response. Importantly, the low-expressing FAAH variant (A-allele carriers) has been associated with improved stress coping and increased rates of obesity in humans. Thus, the FAAH variant is positioned to moderate stress-induced metabolic outcomes. The proposed project will be the first to examine whether genetic variants of FAAH predict individual susceptibility to obesity in response to chronic GC exposure. We will employ a mouse model, which recapitulates the common human mutation in the FAAH gene (C385A), to investigate the effects of differential FAAH expression (between C- and A-allele carriers) on feeding and energy expenditure. This project has the potential to establish a molecular link between energy balance and stress, and help to explain why diverging metabolic outcomes arise when confronted with stress. Together, the outcomes of these studies may have implications for obesity prevention, via lifestyle modification (stress reduction) in genetically susceptible individuals.
Competitiondate
201709
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Balsevich, Georgia
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~
University of Calgary - $140,000 Grant (2017-18) | Canada Spends